6 results match your criteria: "Milken Institute Center for Strategic Philanthropy[Affiliation]"
Bipolar Disord
December 2023
Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Front Neurosci
September 2023
Milken Institute Center for Strategic Philanthropy, Washington, DC, United States.
J Affect Disord
February 2022
National Network of Depression Centers, Ann Arbor, MI, USA; Department of Psychiatry, University of Iowa, Iowa City, IA, USA; Office of Rural Health Resource Center, Iowa City VA Health Care System, Iowa City IA, USA; Center for Access Delivery Research and Evaluation, Iowa City VA Health Care System, Iowa City IA, USA.
Background: The lived experience of people with mood disorders may be leveraged to inform priorities for research, define key treatment outcomes, and support decision-making in clinical care. The aim of this mixed-methods project was to provide insight into how people with depression and bipolar disorder experience the impact of symptoms, their treatment preferences, and their definitions of wellness.
Methods: The project was implemented in two phases.
Hum Brain Mapp
January 2022
Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
MRI-derived brain measures offer a link between genes, the environment and behavior and have been widely studied in bipolar disorder (BD). However, many neuroimaging studies of BD have been underpowered, leading to varied results and uncertainty regarding effects. The Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) Bipolar Disorder Working Group was formed in 2012 to empower discoveries, generate consensus findings and inform future hypothesis-driven studies of BD.
View Article and Find Full Text PDFElife
September 2019
Milken Institute Center for Strategic Philanthropy, Washington, United States.
The Aligning Science Across Parkinson's (ASAP) initiative is building an international network of researchers to improve our understanding of the biology underlying Parkinson's disease. Developing a better understanding of how the disease originates and progresses will, we hope, lead to new therapies. The ASAP initiative will incentivize collaboration between the existing PD research community and other researchers and will be committed to open-science practices.
View Article and Find Full Text PDF